Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-8081017

  • Global Coronary Stent Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: October 2017 | Report Code: HME-8081017

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Coronary stent market is the market of coronary stent which are utilized for opening the artery during coronary heart procedures such as, angioplasty specifically in percutaneous coronary intervention (PCI). PCI procedure is helpful in reducing angina and helps in increasing survival probabilities of patient. The global coronary stent market is expected to grow at a CAGR of 7.10% during forecast period 2016-2023. Increasing Geriatric Population, Rising Incidence of Coronary Artery Disease are the major drivers contributing to the growth of global coronary stent market. According to national program from prevention and control diabetes, stroke and CVD, in India, it is estimated that by the end of 2020, cardio artery diseases would be one of the major factor that results in mortality.

Whereas, availability of alternative treatment methods for coronary artery disease such as Enhanced external counter pulsation (EECP), stringent regulations for product approval and product failure and product recalls are some factors that are restricting the market growth.

Rising geriatric population increases risk for prevalence of coronary heart disease that is likely to reflect positive effect in growth of global coronary stent market. According to National Center for Bio-technology Information Western countries are majorly affected by Coronary health diseases and this condition resulting in death of one third of older people. In addition to this, according to American Heart Association statics on heart disease and stroke 2016, around 15.5 million people in United States of America were affected from coronary heart disease. This prevalence of CHD is high in men with around 37.5% and in women in 18.3%. As per National institute of health (NIH), United States, has accounted about 8.5 % of old aged population. It is expected that the geriatric population is likely to reach up to approximately 1.6 billion by the end of 2050. Moreover, According to World Health Organization (WHO), in 2015, about 125 million people were   of 80 years and above in United States. Thus, the rising geriatric population is increasing the prevalence of coronary heart diseases which is boosting global coronary stents market.

Source: OBRC Analysis

The report on global coronary stent market is segmented on the basis of its segments which include: type, mode of delivery, material and end user.

The type of coronary stent in market includes:

  • Bare-Metal Stents
  • Drug-Eluting Stents
  • Bioabsorbable Stents




Mode of delivery in coronary stent market includes:

  • Balloon-Expandable Stents
  • Self-Expanding Stents



End user segment of coronary stent market includes:

  • Metallic Stents
  • Other Stents



The end users adopting coronary stent include:

  • Hospitals
  • Cardiac centers
  • Ambulatory Surgical Centers




The report scope is widely categorized on the basis of its segments such as type, mode of delivery, material and end user.

Geographically, the coronary stent market report has been segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is expected to dominate the market for the forecast period 2016-2023 followed by Asia pacific, Europe and Rest of the World. North America accounted for the largest market share in terms of revenue due to planned reimbursement policies, high healthcare spending. However according to OBRC analysis Asia pacific is expected to grow at a faster CAGR during the forecast period 2016-2023 due to positive effect of market factors in the region such as, rising prevalence of cardiac diseases, increasing adoption of advance technology in the region and low manufacturing costs in the region. Moreover presence and increasing focus of key players of coronary stent market in the region is expected to contribute in the growth of coronary stent market in Asia.

Global coronary stent market report covers segmentation analysis of type, mode of delivery, material and end user. Report further covers segmentation analysis of coronal stent type which includes Bare-Metal Stents, Drug-Eluting Stents, Bioabsorbable Stents. Drug eluting stent segment is expected to dominate during the forecast period 2016-2023 due to the advantages of drug eluting stents such as, low risk of restenosis and less complications and low cost procedure. Segmentation on the basis of mode of delivery the coronary stent market is sub-segmented into Balloon-Expandable Stents and Self-Expanding Stents. Balloon expandable stent sub-segment of mode of delivery is expected to dominate the market during forecast period 2016-2023 due to increasing research in accordance to improve technology and growing regulatory approvals for balloon-expandable stents. Material segment of global coronary stent market is segmented into Metallic Stents and Other Stents. Other segment is expected to dominate market due to increasing utilization of polymers and copolymers for developing bioabsorbable stent. On the basis of end user the market is segmented into Hospitals, Cardiac Centers and Ambulatory Surgical Centers. Hospital segment in end user is expected to dominate the market for the forecast period 2016-2023 owning to high utilization of coronary stent in hospitals.

The major market players of the global healthcare workforce management systems market are:

  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION.
  • BIOSENSORS INTERNATIONAL GROUP, LTD.
  • BIOTRONIK SE & CO. KG
  • B. BRAUN MELSUNGEN AG
  • OTHER







These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch whereas, mergers, acquisition and partnership is the key strategy adopted by the companies in the coronary stent market.

 

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in the global coronary stent market.

Key reasons to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023 of the global coronary stent market.
  • Report includes detailed analysis of different segments such as type, mode of delivery, material and end user of the global coronary stent market.
  • Identify and understand the strength, opportunities, challenges and threat of the global coronary stent market during the forecast period.
  • Covers details analysis of Porters 5 force model and other strategic models. Also covers revenues, market share analysis, and competitive landscape analysis of major players of the global coronary stent market.
  • Detailed analysis of various the regulatory policies which are affecting the global coronary stent market during the forecast period.






How are we different from others?

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on the global coronary stent market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the global coronary stent market, with giving extensive SCOT analysis of key companies.

Key findings of the global coronary stent market:

  • Large expenditure on healthcare services are adding growth in the global coronary stent market during the forecast period.
  • Rising Incidence of Coronary Artery Disease and Subsequent Growth in the Number of PCI Procedures adding growth in the global coronary stent market.
  • North America held highest revenue share in 2016 and is expected to dominate the market during the forecast period.
  • Bioabsorbable Stents to be the fastest growing type segment during the forecast period.
  • Mergers and acquisition is the key strategy adopted by players of the global coronary stent market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL CORONARY STENT MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. TECHNOLOGICAL ADVANCEMENTS
3.1.2. RISING INCIDENCE OF CORONARY ARTERY DISEASE AND SUBSEQUENT GROWTH IN THE NUMBER OF PCI PROCEDURES
3.1.3. INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
3.1.4. RISING GERIATRIC POPULATION
3.2. MARKET RESTRAINTS
3.2.1. AVAILABILITY OF ALTERNATIVE TREATMENT METHODS FOR CORONARY ARTERY DISEASE
3.2.2. STRINGENT REGULATIONS FOR PRODUCT APPROVAL
3.2.3. PRODUCT FAILURE AND PRODUCT RECALLS
3.3. MARKET OPPORTUNITIES
3.3.1. BIORESORBABLE VASCULAR SCAFFOLDS
3.3.2. EMERGING MARKETS
3.4. MARKET CHALLENGES 
3.4.1. COMPLICATIONS ASSOCIATED WITH IMPLANTATION OF STENTS
3.4.2. DECLINING COSTS OF STENTS
 
4. MARKET SEGMENTATION
4.1. GLOBAL CORONARY STENT MARKET BY TYPE 
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL BALLOON-EXPANDABLE STENTS MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL SELF-EXPANDING STENTS MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.2. GLOBAL  CORONARY STENT MARKET BY MATERIAL
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL METALLIC STENTS MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL OTHER STENTS MARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.3. GLOBAL CORONARY STENT MARKET BY END USER
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL HOSPITALS MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL CARDIAC CENTERS MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL AMBULATORY SURGICAL CENTERS MARKET
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.3.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION 
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GLOBAL CORONARY STENT MARKET BY REGION 
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023  ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. REST OF EUROPE
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. REST OF ASIA PACIFIC
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. MEDTRONIC PLC (U.S)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. ABBOTT LABORATORIES (U.S).
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.2.5. STRATEGIC ANALYSIS
7.3. BOSTON SCIENTIFIC CORPORATION.(U.S)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. BIOSENSORS INTERNATIONAL GROUP, LTD (SINGAPORE).
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. BIOTRONIK SE & CO. KG (GERMANY).
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. B. BRAUN MELSUNGEN AG (GERMANY)
7.6.1. OVERVIEW
7.6.2. STRATEGIC INITIATIVES 
7.6.3. SCOT ANALYSIS 
7.6.4. STRATEGIC ANALYSIS
7.7. TERUMO CORPORATION (JAPAN).
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.7.5. STRATEGIC ANALYSIS
7.8. STENTYS SA (FRANCE)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. MICROPORT SCIENTIFIC CORPORATION (CHINA)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. MERIL LIFE SCIENCES PVT. LTD (INDIA)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. VASCULAR CONCEPTS LIMITED (INDIA).
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. TRANSLUMINA GMBH (GERMANY)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. FORTIMEDIX B.V.
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. I.B.S. S.P.A
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. MICROPORT SCIENTIFIC CORPORATION
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL VASCULAR STENT MARKET BY TYPE 2014-2023 ($ MILLION)
2. GLOBAL BARE-METAL STENTS BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL DRUG-ELUTING STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL BIOABSORBABLE STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL CORONARY STENT MARKET BY MODE OF DELIVERY2014-2023 ($ MILLION)
6. GLOBAL BALLOON-EXPANDABLE STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL SELF-EXPANDING STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL CORONARY STENT MARKET BY MATERIAL 2014-2023 ($ MILLION)
9. GLOBAL METALLIC STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL OTHER STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL CORONARY STENT MARKET BY END USER 2014-2023 ($ MILLION)
12. GLOBAL HOSPITALSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL CARDIAC CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL AMBULATORY SURGICAL CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. NORTH AMERICA CORONARY STENT MARKET 2014-2023 ($ MILLION)
16. EUROPE CORONARY STENT MARKET 2014-2023 ($ MILLION)
17. ASIA PACIFIC CORONARY STENT MARKET 2014-2023 ($ MILLION)
18. REST OF THE WORLD CORONARY STENT MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL VASCULAR STENT MARKET BY TYPE 2014-2023 ($ MILLION)
2. GLOBAL BARE-METAL STENTS 2014-2023 ($ MILLION)
3. GLOBAL DRUG-ELUTING STENTS MARKET 2014-2023 ($ MILLION)
4. GLOBAL BIOABSORBABLE STENTS MARKET 2014-2023 ($ MILLION)
5. GLOBAL CORONARY STENT MARKET BY MODE OF DELIVERY2014-2023 ($ MILLION)
6. GLOBAL BALLOON-EXPANDABLE STENTS MARKET 2014-2023 ($ MILLION)
7. GLOBAL SELF-EXPANDING STENTS MARKET 2014-2023 ($ MILLION)
8. GLOBAL CORONARY STENT MARKET BY MATERIAL 2014-2023 ($ MILLION)
9. GLOBAL METALLIC STENTS MARKET 2014-2023 ($ MILLION)
10. GLOBAL OTHER STENTS MARKET 2014-2023 ($ MILLION)
11. GLOBAL CORONARY STENT MARKET BY END USER 2014-2023 ($ MILLION)
12. GLOBAL HOSPITALSMARKET BY Y 2014-2023 ($ MILLION)
13. GLOBAL CARDIAC CENTERSMARKET  2014-2023 ($ MILLION)
14. GLOBAL AMBULATORY SURGICAL CENTERSMARKET 2014-2023 ($ MILLION)
15. UNITED STATES (U.S.) CORONARY STENT MARKET 2014-2023 ($ MILLION)
16. CANADA CORONARY STENT MARKET 2014-2023 ($ MILLION)
17. UNITED KINGDOM (UK) CORONARY STENT MARKET 2014-2023 ($ MILLION)
18. FRANCE CORONARY STENT MARKET 2014-2023 ($ MILLION)
19. GERMANY CORONARY STENT MARKET 2014-2023 ($ MILLION)
20. SPAIN CORONARY STENT MARKET 2014-2023 ($ MILLION)
21. ROE CORONARY STENT MARKET 2014-2023 ($ MILLION)
22. INDIA CORONARY STENT MARKET 2014-2023 ($ MILLION)
23. CHINA CORONARY STENT MARKET 2014-2023 ($ MILLION)
24. JAPAN CORONARY STENT MARKET 2014-2023 ($ MILLION)
25. AUSTRALIA CORONARY STENT MARKET 2014-2023 ($ MILLION)
26. ROAPAC CORONARY STENT MARKET 2014-2023 ($ MILLION)
27. LATIN AMERICA CORONARY STENT MARKET 2014-2023 ($ MILLION)
28. MENA CORONARY STENT MARKET 2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion